Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elotuzumab for the treatment of multiple myeloma.

Elotuzumab for the treatment of multiple myeloma. Future Oncol. 2014 May; 10(6):949-56.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.